Basic Information
ID: ALA4672613
Type: Functional
Description: Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as increased numbers of necrotic cells at 6 mg/kg, iv dosed once every 2 days for 18 days by H and E staining based analysis relative to control
Format: BAO_0000218
Organism: Homo sapiens
Cell type: BXPC-3
Target: Unchecked(ALA612545)
Document: ALA4665887
Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as increased numbers of necrotic cells at 6 mg/kg, iv dosed once every 2 days for 18 days by H and E staining based analysis relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4672613
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 480.52 | 3.99 | 3.99 |